JOHANNESBURG (Reuters) – Aspen Pharmacare has concluded a set of agreements with the Gates Foundation and the Coalition for Epidemic Preparedness Innovations to receive $30 million in funding to support its capabilities to manufacture vaccines for Africa, it said on Monday.
Aspen signed a deal in August with the Serum Institute of India to manufacture and sell four Aspen-branded vaccines for Africa, as it seeks to utilise its near-idle COVID-19 vaccine production lines in South Africa. It had been expecting to receive grants from the foundations.
(Reporting by Nqobile Dludla, Editing by Louise Heavens)
